TP53-EphA-2-CAR-DC
/ Chinese PLA General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 28, 2023
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Chinese PLA General Hospital | Initiation date: Feb 2023 ➔ Jul 2023
IO biomarker • Metastases • Trial initiation date • Hematological Malignancies • Lymphoma • Oncology • IL10 • IL2 • IL6 • TP53
February 08, 2023
Combination of CAR-DC Vaccine and Anti-PD-1 Antibody in Malignant Tumors
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Chinese PLA General Hospital | N=20 ➔ 10
Enrollment change • IO biomarker • Metastases • Hematological Malignancies • Lymphoma • Oncology • Solid Tumor • IL10 • IL2 • IL6 • TP53
November 30, 2022
Combination of CAR-DC Vaccine and PD-1 Antibody in Malignant Tumors
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Chinese PLA General Hospital
IO biomarker • New P1 trial • Hematological Malignancies • Lymphoma • Oncology • Solid Tumor • IL10 • IL2 • IL6 • TP53
1 to 3
Of
3
Go to page
1